CompletedPhase 2NCT00003019
Vinblastine and Methotrexate in Treating Children With Desmoid Tumors
Studying Desmoid tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Oncology Group
- Principal Investigator
- Steve Skapek, MDSt. Jude Children's Research Hospital
- Intervention
- methotrexate(drug)
- Enrollment
- 28 enrolled
- Eligibility
- 21 years · All sexes
- Timeline
- 1997 – 2006
Study locations (30)
- Long Beach Memorial Medical Center, Long Beach, California, United States
- Children's Hospital Los Angeles, Los Angeles, California, United States
- Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
- Children's Hospital of Orange County, Orange, California, United States
- UCSF Cancer Center and Cancer Research Institute, San Francisco, California, United States
- David Grant Medical Center, Travis Air Force Base, California, United States
- Children's Hospital of Denver, Denver, Colorado, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- University of Chicago Cancer Research Center, Chicago, Illinois, United States
- Indiana University Cancer Center, Indianapolis, Indiana, United States
- University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
- University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
- CCOP - Kalamazoo, Kalamazoo, Michigan, United States
- University of Minnesota Cancer Center, Minneapolis, Minnesota, United States
- Mayo Clinic Cancer Center, Rochester, Minnesota, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI) · Children's Cancer Group
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00003019 on ClinicalTrials.govOther trials for Desmoid tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07541430A Study in Adults With Desmoid TumorsElpiscience (Suzhou) Biopharma, Ltd.
- RECRUITINGPHASE4NCT07176689Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)SpringWorks Therapeutics, Inc.
- ACTIVE NOT RECRUITINGPHASE2NCT07170644A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)SpringWorks Therapeutics, Inc.
- RECRUITINGNCT06945887Treatment of Desmoid Fibromatosis With Arterial EmbolizationIstituto Ortopedico Rizzoli
- RECRUITINGNCT07496242Immunological Phenotype of Desmoid-fibromatosis-affected Patients.Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- RECRUITINGPHASE2NCT05879146Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical StudyM.D. Anderson Cancer Center
- RECRUITINGNCT06660121Electrochemotherapy for Desmoid TumorsIstituto Ortopedico Rizzoli
- RECRUITINGNANCT06081400Cryoablation Versus Medical Therapy in Desmoid Tumors Progressing After Watchful WaitingUniversity Hospital, Strasbourg, France